4//SEC Filing
Siatis Perry C 4
Accession 0001415889-25-006578
CIK 0001551152other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:00 PM ET
Size
23.2 KB
Accession
0001415889-25-006578
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Siatis Perry C
EVP, GC AND SECRETARY
Transactions
- Tax Payment
Common Stock, $0.01 par value
2025-02-28$205.02/sh−7,870$1,613,507→ 14,511 total - Sale
Common Stock, $0.01 par value
2025-02-28$205.38/sh−2,718$558,223→ 11,793 total - Sale
Common Stock, $0.01 par value
2025-02-28$206.62/sh−6,811$1,407,289→ 4,982 total - Exercise/Conversion
Common Stock, $0.01 par value
2025-03-03$175.28/sh+7,775$1,362,802→ 22,627 total - Sale
Common Stock, $0.01 par value
2025-02-28$207.19/sh−363$75,210→ 4,619 total - Exercise/Conversion
Common Stock, $0.01 par value
2025-03-03$144.54/sh+2,918$421,768→ 7,537 total - Exercise/Conversion
Common Stock, $0.01 par value
2025-03-03$149.62/sh+7,315$1,094,470→ 14,852 total - Sale
Common Stock, $0.01 par value
2025-03-03$210.00/sh−18,008$3,781,680→ 4,619 total - Disposition to Issuer
Option (Right to buy)
2025-03-03$144.54/sh−2,918$421,768→ 0 totalExercise: $144.54From: 2023-02-17Exp: 2032-02-16→ Common Stock (2,918 underlying) - Disposition to Issuer
Option (Right to buy)
2025-03-03$149.62/sh−7,315$1,094,470→ 7,314 totalExercise: $149.62From: 2024-02-16Exp: 2033-02-15→ Common Stock (7,315 underlying) - Disposition to Issuer
Option (Right to buy)
2025-03-03$175.28/sh−7,775$1,362,802→ 15,549 totalExercise: $175.28From: 2025-02-15Exp: 2034-02-14→ Common Stock (7,775 underlying)
Footnotes (4)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.99 to $205.98, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.01 to $207, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.12 to $207.37, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001951400
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:00 PM ET
- Size
- 23.2 KB